November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Managing the female patient's needs
February 18th 2005With the hope of presenting practical advice that can be applied clinically to female patients by dermatologists, experts brought forward issues that consistently require attention, with the focus on one therapy that may forever change leg vein therapy.
Injectable silicone shows promise for HIV facial lipoatrophy Tx
February 18th 2005Currently, off-label use of highly purified, medical grade 1000-centisoke silicone oil (Silikon 1000, Alcon Laboratories) as a permanent filler material seems to best fulfill the need for persistent, safe, cost-effective and natural-appearing correction.
Hyperhidrosis' impact 'underestimated'
February 1st 2005St. Louis, Mo. — According to a recent survey, hyperhidrosis afflicts nearly 3 percent of the U.S. population, with about half of sufferers experiencing axillary hyperhidrosis and many patients experiencing social, professional and other consequences that often go unaddressed.
Strong group synergy at second PDA gathering
February 1st 2005Rio de Janeiro, Brazil — Members of the Pigmentary Disorders Academy (PDA) convened here last November for their second annual meeting. While still in its infancy and relatively small in size, the group has already made significant progress as they pursue their mission to optimize care of patients affected by pigmentary disorders.
Florida safety data accrues about in-office surgery risks
February 1st 2005Kissimmee, Fla. — Four years of data collection on the safety of office-based surgery in Florida provides compelling evidence to support conclusions that plastic surgeons and anesthesiologists are responsible for the majority of all serious complications and deaths due to cosmetic surgery.
Sculptra, silicone combat HIV lipoatrophy
February 1st 2005Newport Beach, Calif. — Among treatment options for HIV lipoatrophy, the best choices for most patients are liquid injectable silicone or the recently approved filler Sculptra (Dermik Laboratories), said Derek H. Jones, M.D., at the Pacific Dermatologic Association meeting here.
Versatility weighs in for pulsed dye laser
February 1st 2005Kissimmee, Fla. — A pulsed dye laser (PDL) and intense pulsed light (IPL) source both have roles in a dermatology practice for esthetic and non-esthetic indications. But in a situation where a practice must decide between the two, an IPL is probably the preferred acquisition because it covers a broader range of targets, Vic A. Narurkar, M.D., said at the Orlando Dermatology & Cosmetic Conference here last fall.
Nonablative rejuvenation techniques continue on evolutionary path
February 1st 2005Aruba — A number of nonablative techniques for dermal remodeling can afford improvements in skin texture, tone and elasticity, but a combination approach integrating additional noninvasive techniques, including dermal fillers, botulinum toxin type A injection, chemical peels and/or microdermabrasion, is desirable for enhancing facial rejuvenation, said Elizabeth L. Tanzi, M.D. at the Fourth Annual Caribbean Dermatology Symposium. Dr. Tanzi reviewed recent advances in nonablative rejuvenation, including the use of photodynamic therapy (PDT), radiofrequency skin tightening and photomodulation.
Chemical peels still affordable, efficient workhorse
February 1st 2005Stanford, Calif. — Against the numerous advances in cosmetic dermatology, chemical peels retain a valuable role as a time-proven, safe and cost-effective modality for aging skin rejuvenation and other indications, according to Cherie M. Ditre, M.D.
How to optimize radiofrequency treatment results
February 1st 2005Lake Buena Vista, Fla. - David Goldberg, M.D., says that for prospective cosmetic surgery patients wishing to quickly but effectively tighten facial wrinkles, radiofrequency (RF) rejuvenation - particularly with the ThermaCool ?TC machine developed by Thermage ?, which won federal approval as a full-face treatment last July - may be the way to go.